Covalis Capital’s Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 ACII.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,298
Closed -$38K 106
2022
Q1
$38K Sell
10,298
-2,201
-18% -$977 0.01% 79
2021
Q4
$52K Hold
12,499
0.02% 80
2021
Q3
$52K Hold
12,499
0.01% 122
2021
Q2
$57K Buy
+12,499
New +$13.2K 0.02% 126

Other funds holding ACII.WS

Covalis Capital's ACII.WS Position: Q2 2022 in Review

Covalis Capital sold out of Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 (ACII.WS) in Q2 2022, closing a stake of 10,298 shares — an estimated $38K sold.

Covalis Capital first reported a position in ACII.WS in Q2 2021 and held it in 4 quarters. The position peaked at $57K in Q2 2021. 51 funds tracked by Wall St. Rank hold ACII.WS as of Q2 2022.

  • Covalis Capital reported no remaining Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 position as of Q2 2022 after selling out during the quarter.
  • Covalis Capital sold 10,298 Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 shares in Q2 2022, an estimated $38K.
  • Covalis Capital first reported a position in Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 in Q2 2021 and held it in 4 quarters.
  • Covalis Capital's Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 position peaked at $57K in Q2 2021.
  • 51 funds tracked by Wall St. Rank held Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 as of Q2 2022.

Based on Covalis Capital's 13F filing for Q2 2022, filed 15 Aug 2022.